After being cleared to submit existing trial data to back up its IND application for pain formulation MoxDuo IR, QRxPharma (ASX:QRX) now expects the US FDA to make its decision in mid-2013. [ + ]

pSivida (ASX:PVA) licensee Alimera has scored a win in efforts to gain UK acceptance for the Iluvien micro-insert as a treatment for chronic diabetic macular edema (DME). [ + ]

AusBiotech has announced it will hold its annual general meeting at the AusBiotech 2012 national conference in Melbourne on Thursday 1 November 2012 at 1:00pm, where business will include the outcome of the election for two directors to join the AusBiotech Board. [ + ]

It has taken nearly a decade of hard work, but the first pages of an ‘Encyclopaedia Genomica’ have been published by an international consortium of researchers, revealing some surprising insights about the human genome. [ + ]

The NSW government has launched a seven-figure fund to encourage the development and commercialisation of innovative medical devices in the state. [ + ]

Avita Medical (ASX:AVH) will raise up to $10m through a placement and SPP to support marketing and US commercialisation efforts for its ReCell Spray-On Skin technology. [ + ]

The best young Australian scientists will have the chance to be mentored by Nobel Prize winners, thanks to a new collaboration between the Australian Academy of Science and the Science and Industry Endowment Fund. [ + ]

The event, to be held in Melbourne – 30 October - 2 November 2012 – will feature expert speakers from overseas and Australia, who will speak on investment, public policy, industry experiences and business development. [ + ]

New Zealand's Innate Immunotherapeutics has launched a US$10 million ($9.75 million) capital raising to help fund an Australian trial of a prospective treatment for progressed multiple sclerosis. [ + ]

Azure Healthcare (ASX:AZV), shed of its unprofitable audio visual business, swung to a $744,000 net profit for FY12. [ + ]

Cystic fibrosis (CF) is an extremely nasty disease. It is the most common inherited, life-shortening condition affecting Australian children. It is an autosomal recessive disorder caused by mutations in the cystic fibrosis trans-membrane conductance regulator (CFTR), a transport protein found in epithelial linings. [ + ]

Life Technologies Corporation and Sino Biological have announced a partnership for worldwide product distribution and product development. Life Technologies will distribute Sino Biological’s portfolio of recombinant proteins, antibodies and Elisa kits through its global distribution channels. [ + ]

In what is akin to finding a needle in a haystack, a genetic discovery has helped medical researchers in Newcastle take a further stride towards predetermining the risk factors for stroke. [ + ]

Genetic Technologies (ASX:GTG) has filed a patent suit against California's Reproductive Genetics Institute, in the newest enforcement effort for its non-coding DNA patents. [ + ]

Commercialisation Australia has granted a $50,000 grant to help bring Nexgen – an anti-viral technology for plants developed at The University of Queensland – to market. [ + ]